graph Evidence gap map comparisons
ribociclib based treatment
ribociclib plus endocrine therapy ribociclib plus fulvestrant ribociclib plus letrozole
Comparator:  vs letrozole;   vs endocrine therapy;   vs fulvestrant; 
Risk of bias:  low;   some concerns;   high;  NA;